Qiagen Wastewater Surveillance Testing Reagents and Service

The State of Colorado, through the Colorado Department of Public Health and Environment’s Division of Disease Control and Public Health Response, is proceeding with a sole source procurement from QIAGEN for wastewater surveillance testing reagents and services, identified by solicitation number NPSS1-FHCA-2026000216-1. The contract, which spans from December 15, 2023, to December 14, 2028, covers the acquisition of two QIAGEN QIAcuity digital polymerase chain reaction instruments, associated reagents and supplies, and a five-year service agreement renewal for the original instrument. This procurement is justified on the grounds that QIAGEN’s dPCR platform is the only system capable of performing the specialized wastewater pathogen quantification required by the CSPHL wastewater surveillance unit, and that all existing protocols and automation workflows are built around this proprietary technology. The contract’s revised estimated value is $3.14 million, an increase from the original $1.64 million due to heightened testing volumes that necessitate additional reagent procurement. The contracting office is located in Denver, Colorado, and the NAICS code for this action is 325413. No competitive solicitation has been issued; instead, this is a sole source action under federal acquisition guidelines, with comments or objections to be directed to Kristi Gamble by the response deadline of May 28, 2026. Failure to receive objections will result in the continuation of business with QIAGEN under this arrangement.